Skip to main content

Table 5 Discordant HPV test results resolved by their HPV genotype detected by INNO-LiPA genotyping

From: A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off

HPV genotype HPV classification HR HC2-ve, CER+ve (N) CER-ve, HR HC2+ve (N) Histology CIN2+ (HC2-ve/CER-ve)
HPV16* HR 4 4 0/2
HPV18* HR 0 1 0/1
HPV31* HR 0 3 0
HPV33* HR 0 1 0
HPV39* HR 1 1 0
HPV51* HR 1 6 0
HPV52* HR 1 4 0
HPV66** HR 2 1 0
HPV68* Intermediate 0 2 0
HPV53 Intermediate 1 11 0
HPV6 LR 0 1 0
HPV54 LR 0 1 0
HPV69/71 LR 1 0 0
HPV74 LR 1 1 0
HPVX   2 2 0
HPV DNA negative   56 3 0
no result (sample failed)   19 2 0
Total   89 44 3
  1. *HC2 and Cervista target types; **Cervista target type; HPVX: HPV DNA was detected by LiPA, but could not be correlated to a specific type; +ve: positive; −ve: negative.